MedPath

The efficacy and safety of Shuanhuanglian oral solution(child type) in the treatment of acute upper respiratory tract infection (wind-heat-induced syndrome) in children: multicenter, randomized, double-blind, controlled trial

Phase 2
Completed
Conditions
Acute upper respiratory tract infection in children
Registration Number
ITMCTR2000003337
Lead Sponsor
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. In line with the western medicine diagnostic criteria of acute upper respiratory tract infection;
2. In children caused by exogenous windd-heat cold disease diagnostic criteria;
3. Aged 1 to 7 years old;
4. The course of the disease is not more than 24 hours;
5. Parents or guardian signed informed consent.

Exclusion Criteria

1. Do not accord with standard of this disease diagnosis and syndrome dialectical criteria;
2. The early infantile acute infectious diseases, acute infectious laryngitis, suppurative tonsillitis, pneumonia, respiratory diseases such as bronchitis, capillary bronchitis;
3. The temperature38.5 degree C;
4. The pharyngeal swelling > 4 points;
5. WBC>12x10^9/L, CRP>10mg/L;
6. Has a history of febrile convulsion, severe malnutrition. Or with other heart, liver, kidney and hematopoietic system, such as serious primary diseases;
7. This research institute with medicine allergic constitution and composition are allergic;
8. Patients who are participating in clinical trials of other drugs;
9. According to the doctor, easy to cause loss of visitor.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
temperature;
Secondary Outcome Measures
NameTimeMethod
TCM syndrome changes;
© Copyright 2025. All Rights Reserved by MedPath